We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

8 hedge funds and large institutions have $4.62M invested in Abiomed Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 499 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

98% less funds holding

Funds holding: 517 → 8 (-509)

99% less call options, than puts

Call options by funds: $437K | Put options by funds: $45.7M

100% less capital invested

Capital invested by funds: $10.5B → $4.62M (-$10.5B)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 499

Holders
8
Holders Change
-509
Holders Change %
-98.45%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
6
Closed
499
Calls
$437K
Puts
$45.7M
Net Calls
-$45.2M
Net Calls Change
-$79.7M

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$14K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.29B
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$1.21B
3
BlackRock
BlackRock
New York
-$1.12B
4
State Street
State Street
Massachusetts
-$509M
5
Primecap Management
Primecap Management
California
-$370M
Name Holding Trade Value Shares
Change 		Change in
Stake
JWA
476
JFS Wealth Advisors
Pennsylvania
– -$4K -16 Closed
UB
477
UMB Bank
Missouri
– -$4K -15 Closed
SC
478
Schubert & Co
Texas
– -$3K -14 Closed
PWMG
479
Prestige Wealth Management Group
New Jersey
– -$3K -13 Closed
AF
480
Allworth Financial
California
– -$3K -12 Closed
DCM
481
Davidson Capital Management
Texas
– -$3K -11 Closed
TC
482
Truvestments Capital
Florida
– -$3K -11 Closed
ATC
483
Adirondack Trust Company
New York
– -$2K -10 Closed
AFS
484
Annapolis Financial Services
Maryland
– -$2K -10 Closed
EIP
485
Ellis Investment Partners
Pennsylvania
– -$2K -10 Closed
SIC
486
Salem Investment Counselors
North Carolina
– -$2K -10 Closed
SC
487
Stephens Consulting
Michigan
– -$2.46K -10 Closed
LF
488
Lee Financial
Texas
– -$2K -8 Closed
SFO
489
Standard Family Office
South Dakota
– -$2K -8 Closed
HFM
490
Harvest Fund Management
China
– -$2K -7 Closed
MCC
491
Money Concepts Capital
Florida
– -$2K -7 Closed
EWA
492
EverSource Wealth Advisors
Alabama
– -$1K -6 Closed
KFI
493
Key Financial Inc
Pennsylvania
– -$1K -6 Closed
LFG
494
Larson Financial Group
Missouri
– -$1K -6 Closed
FP
495
Financial Perspectives
Minnesota
– -$1.23K -5 Closed
QC
496
Quent Capital
New York
– -$1K -5 Closed
CB
497
Community Bank
New York
– -$1K -4 Closed
DI
498
Disciplined Investments
Oklahoma
– -$1K -4 Closed
GI
499
Gradient Investments
Minnesota
– -$1K -3 Closed
AWM
500
Abound Wealth Management
Tennessee
– -$246 -1 Closed
16 17 18 19
20

ABMD Hedge Fund Activity: Q4 2022 in Review

8 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2022, worth a combined $4.62M — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 499 funds closed out of ABMD and 0 opened new positions — a net loss of 499 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $14K. The largest seller was Vanguard Group, exiting entirely with an estimated $1.29B sold.

  • 8 institutional investors held Abiomed Inc (ABMD) as of Q4 2022, down from 517 in Q3 2022.
  • Funds reported $4.62M of Abiomed Inc stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Abiomed Inc positions in Q4 2022 and 499 closed out, a net change of -499 holders.
  • The largest Abiomed Inc buyer in Q4 2022 was Blue Trust Inc, an estimated $14K added.
  • The largest Abiomed Inc seller in Q4 2022 was Vanguard Group, an estimated $1.29B sold.

Based on aggregated 13F filings for Q4 2022.